Shenzhen New Industries Biomedical (SHE:300832) — Market Cap & Net Worth
Market Cap & Net Worth: Shenzhen New Industries Biomedical (300832)
Shenzhen New Industries Biomedical (SHE:300832) has a market capitalization of $5.64 Billion (CN¥38.56 Billion) as of September 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #3292 globally and #425 in its home market, demonstrating a -0.12% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shenzhen New Industries Biomedical's stock price CN¥49.08 by its total outstanding shares 785718785 (785.72 Million). Also see Shenzhen New Industries Biomedical balance sheet assets for a full breakdown of the balance sheet.
Shenzhen New Industries Biomedical Market Cap History: 2020 to 2026
Shenzhen New Industries Biomedical's market capitalization history from 2020 to 2026. Data shows growth from $7.62 Billion to $5.64 Billion (13.08% CAGR). Also see Shenzhen New Industries Biomedical (300832) cash conversion ratio for how efficiently the company converts equity into cash flow.
Index Memberships
Shenzhen New Industries Biomedical is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ChiNext
CNT
|
$1.15 Trillion | 0.49% | #44 of 100 |
Weight: Shenzhen New Industries Biomedical's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Shenzhen New Industries Biomedical Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shenzhen New Industries Biomedical's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Shenzhen New Industries Biomedical share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.80x
Shenzhen New Industries Biomedical's market cap is 1.80 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.46x
Shenzhen New Industries Biomedical's market cap is 4.46 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $7.62 Billion | $2.19 Billion | $939.15 Million | 3.47x | 8.12x |
| 2021 | $4.87 Billion | $2.55 Billion | $973.70 Million | 1.91x | 5.00x |
| 2022 | $5.62 Billion | $3.05 Billion | $1.33 Billion | 1.84x | 4.23x |
| 2023 | $8.87 Billion | $3.93 Billion | $1.65 Billion | 2.26x | 5.37x |
| 2024 | $8.15 Billion | $4.54 Billion | $1.83 Billion | 1.80x | 4.46x |
Competitor Companies of 300832 by Market Capitalization
Companies near Shenzhen New Industries Biomedical in the global market cap rankings as of September 19, 2026. Review 300832 goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Shenzhen New Industries Biomedical by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #126 globally with a market cap of $177.76 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #235 globally with a market cap of $107.45 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Abbott Laboratories | NYSE:ABT | $177.76 Billion | $102.23 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.77 |
| #235 | Stryker Corporation | NYSE:SYK | $107.45 Billion | $280.13 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Shenzhen New Industries Biomedical Historical Marketcap From 2020 to 2026
Between 2020 and today, Shenzhen New Industries Biomedical's market cap moved from $7.62 Billion to $ 5.64 Billion, with a yearly change of 13.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥5.64 Billion | -12.75% |
| 2025 | CN¥6.47 Billion | -20.61% |
| 2024 | CN¥8.15 Billion | -8.21% |
| 2023 | CN¥8.87 Billion | +57.88% |
| 2022 | CN¥5.62 Billion | +15.44% |
| 2021 | CN¥4.87 Billion | -36.11% |
| 2020 | CN¥7.62 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Shenzhen New Industries Biomedical was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.64 Billion USD |
| MoneyControl | $5.64 Billion USD |
| MarketWatch | $5.64 Billion USD |
| marketcap.company | $5.64 Billion USD |
| Reuters | $5.64 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shenzhen New Industries Biomedical
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was found… Read more